Article Details

China's CanSino reports 'positive' interim data from COVID mRNA booster trial | Reuters

Retrieved on: 2023-01-05 20:08:50

Tags for this article:

Click the tags to see associated articles and topics

China's CanSino reports 'positive' interim data from COVID mRNA booster trial | Reuters. View article details on hiswai:

Excerpt

China's CanSino Biologics Inc reported on Thursday "positive" interim data from its experimental COVID-19 mRNA booster vaccine in a mid-stage ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up